Markets:

Overview

News

Currencies

International

Treasuries

RVL Pharmaceuticals plc - Ordinary Shares (NQ:RVLP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 20, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RVL Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 20, 2023

Via Benzinga

Earnings Outlook For RVL Pharmaceuticals plc - Ordinary Shares ↗

March 17, 2023

Via Benzinga

RVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed Overview ↗

December 21, 2022

Via Benzinga

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Netflix To Rally Around 17%? Plus This Analyst Predicts $144 For Electronic Arts ↗

October 25, 2022

Daiwa Capital boosted the price target on Netflix, Inc. (NASDAQ: NFLX) from $226 to $330. Daiwa Capital analyst Satoshi Tanaka upgraded the stock from Neutral to Outperform. Netflix shares fell 2.5% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 24, 2022

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 19, 2022

Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 19, 2022

Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment ↗

July 08, 2022

Via Benzinga

Why Golden Ocean Group Is Trading Higher By 7%; Here Are 28 Stocks Moving Premarket ↗

September 26, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 23, 2022

Gainers

Via Benzinga

7 Stocks to Sell Now ↗

July 19, 2022

Not all stocks will benefit even if the markets turn around. These stocks to sell are likely to keep going lower, rather than rebounding.

Via InvestorPlace

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday ↗

September 15, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

Via Benzinga

RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview ↗

May 11, 2022

RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.

Via Benzinga

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2022

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Via Benzinga

RVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed Insights ↗

March 31, 2022

Benzinga Pro data, RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) reported Q4 sales of $2.86 million. Earnings fell to a loss of $19.72 million, resulting in a 10.43% decrease from last...

Via Benzinga

RVL Pharmaceuticals plc - Ordinary Shares's Earnings: A Preview ↗

March 29, 2022

RVL Pharmaceuticals plc - Ordinary Shares (NASDAQ:RVLP) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement.

Via Benzinga

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session ↗

August 15, 2022

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 18, 2022

Gainers

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Earnings Scheduled For March 30, 2022 ↗

March 30, 2022

Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 24, 2022

Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

RVL Pharmaceuticals plc - Ordinary Shares (NQ:RVLP)

All News about RVL Pharmaceuticals plc - Ordinary Shares

Starting at $3.75/week.

Subscribe Today